Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             48 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparison of insight into clinical symptoms versus insight into neuro-cognitive symptoms in schizophrenia Medalia, Alice
2010
118 1-3 p. 134-139
6 p.
artikel
2 Altered activation and functional connectivity of neural systems supporting cognitive control of emotion in psychosis proneness Modinos, Gemma
2010
118 1-3 p. 88-97
10 p.
artikel
3 A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case–control and family-based sample of German ancestry Strohmaier, Jana
2010
118 1-3 p. 98-105
8 p.
artikel
4 Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome Stoddard, Joel
2010
118 1-3 p. 118-121
4 p.
artikel
5 Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia An, Suk Kyoon
2010
118 1-3 p. 54-61
8 p.
artikel
6 Body image in individuals with schizophrenia: Examination of the B-WISE® questionnaire Arbour-Nicitopoulos, Kelly P.
2010
118 1-3 p. 307-308
2 p.
artikel
7 Challenging the assumption that improvement in functional outcomes is delayed relative to improvement in symptoms in the treatment of schizophrenia Kinon, Bruce J.
2010
118 1-3 p. 176-182
7 p.
artikel
8 Cognitive decline in schizophrenia from childhood to midlife: A 33-year longitudinal birth cohort study Kremen, William S.
2010
118 1-3 p. 1-5
5 p.
artikel
9 Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia Fatemi, S. Hossein
2010
118 1-3 p. 303-304
2 p.
artikel
10 Deconstructing processing speed deficits in schizophrenia: Application of a parametric digit symbol coding test Bachman, Peter
2010
118 1-3 p. 6-11
6 p.
artikel
11 Developmental instability in social anhedonia: An examination of minor physical anomalies and clinical characteristics Blanchard, Jack J.
2010
118 1-3 p. 162-167
6 p.
artikel
12 Do inter-regional gray-matter volumetric correlations reflect altered functional connectivity in high-risk offspring of schizophrenia patients? Bhojraj, Tejas S.
2010
118 1-3 p. 62-68
7 p.
artikel
13 DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication Peralta, Victor
2010
118 1-3 p. 168-175
8 p.
artikel
14 Early developmental milestones and risk of schizophrenia: A 45-year follow-up of the Copenhagen Perinatal Cohort Sørensen, Holger J.
2010
118 1-3 p. 41-47
7 p.
artikel
15 Editorial Board 2010
118 1-3 p. IFC-
1 p.
artikel
16 Executive function in schizophrenia: Influence of substance use disorder history Rodriguez-Jimenez, Roberto
2010
118 1-3 p. 34-40
7 p.
artikel
17 Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: A three-stage case–control association study Amagane, Hideki
2010
118 1-3 p. 106-112
7 p.
artikel
18 Formal thought disorder in non-clinical individuals with auditory verbal hallucinations Sommer, Iris E.
2010
118 1-3 p. 140-145
6 p.
artikel
19 Frequency of schizoaffective disorder in an International patient population with psychotic disorders using the Mini-International Neuropsychiatric Interview Canuso, Carla M.
2010
118 1-3 p. 305-306
2 p.
artikel
20 Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population Aleksic, Branko
2010
118 1-3 p. 113-117
5 p.
artikel
21 Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia Prasad, Konasale M.
2010
118 1-3 p. 232-239
8 p.
artikel
22 Has an important test been overlooked? Closure flexibility in schizophrenia Butler, Pamela D.
2010
118 1-3 p. 20-25
6 p.
artikel
23 Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia Fan, Xiaoduo
2010
118 1-3 p. 211-217
7 p.
artikel
24 Impaired facial affect labeling and discrimination in patients with deficit syndrome schizophrenia Strauss, Gregory P.
2010
118 1-3 p. 146-153
8 p.
artikel
25 Intrinsic motivation and learning in a schizophrenia spectrum sample Choi, Jimmy
2010
118 1-3 p. 12-19
8 p.
artikel
26 Is perseveration uniquely characteristic of schizophrenia? Waford, Rachel N.
2010
118 1-3 p. 128-133
6 p.
artikel
27 Memory profiles in schizophrenia: Categorization validity and stability Bell, Morris D.
2010
118 1-3 p. 26-33
8 p.
artikel
28 Neural correlates of reward processing in schizophrenia — Relationship to apathy and depression Simon, Joe J.
2010
118 1-3 p. 154-161
8 p.
artikel
29 Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia Schretlen, David J.
2010
118 1-3 p. 224-231
8 p.
artikel
30 No association between DAO and schizophrenia in a Japanese patient population: A multicenter replication study Ohnuma, Tohru
2010
118 1-3 p. 300-302
3 p.
artikel
31 Novel immune response to gluten in individuals with schizophrenia Samaroo, Diana
2010
118 1-3 p. 248-255
8 p.
artikel
32 Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis Schlosser, Danielle A.
2010
118 1-3 p. 69-75
7 p.
artikel
33 Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression Glantz, Leisa A.
2010
118 1-3 p. 292-299
8 p.
artikel
34 Processing of facial configuration in individuals at ultra-high risk for schizophrenia Kim, Hee Sun
2010
118 1-3 p. 81-87
7 p.
artikel
35 Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients Vernon, Margaret K.
2010
118 1-3 p. 271-278
8 p.
artikel
36 Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: A systematic meta-review Matheson, S.L.
2010
118 1-3 p. 201-210
10 p.
artikel
37 Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort Conus, Philippe
2010
118 1-3 p. 256-263
8 p.
artikel
38 Schizophrenia in Medline 1950–2006: A bibliometric investigation Theander, Sten S.
2010
118 1-3 p. 279-284
6 p.
artikel
39 Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse Poirier, Simon
2010
118 1-3 p. 285-291
7 p.
artikel
40 Severe injuries in adolescence predict psychosis: A nested case control study of the Northern Finland 1966 Birth Cohort Luoma, Suvi
2010
118 1-3 p. 48-53
6 p.
artikel
41 Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia Severance, Emily G.
2010
118 1-3 p. 240-247
8 p.
artikel
42 Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation Schlagenhauf, Florian
2010
118 1-3 p. 189-200
12 p.
artikel
43 The Health and Recovery Peer (HARP) Program: A peer-led intervention to improve medical self-management for persons with serious mental illness Druss, Benjamin G.
2010
118 1-3 p. 264-270
7 p.
artikel
44 The psychiatric symptomatology of deficit schizophrenia: A meta-analysis Cohen, Alex S.
2010
118 1-3 p. 122-127
6 p.
artikel
45 The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes Müller, Helge
2010
118 1-3 p. 309-310
2 p.
artikel
46 Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients Jäger, M.
2010
118 1-3 p. 183-188
6 p.
artikel
47 Time-to-pregnancy and risk of schizophrenia Opler, Mark G.A.
2010
118 1-3 p. 76-80
5 p.
artikel
48 Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial Narula, Preeta Kaur
2010
118 1-3 p. 218-223
6 p.
artikel
                             48 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland